Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Journal of Cutaneous Medicine and Surgery
|
April 25, 2006
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches
Richard G Langley, Vincent Ho, Charles Lynde, et al.
Journal of Drugs in Dermatology : JDD
|
October 11, 2022
Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis
Charles Lynde, Yves Poulin, Jerry Tan, et al.
Dermatology and Therapy
|
December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
David Pariser, Ellen Frankel, Joel Schlessinger, et al.
Journal of Cutaneous Medicine and Surgery
|
February 23, 2018
OBSERVE-5: Comparison of Etanercept-Treated Psoriasis Patients From Canada and the United States
Kim A Papp, Marc Bourcier, Yves Poulin, et al.
Journal of the American Academy of Dermatology
|
September 21, 2010
Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
Kim A Papp, Yves Poulin, Robert Bissonnette, et al.
Cutis
|
September 15, 2009
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne
Linda Stein Gold, Jerry Tan, Alma Cruz-Santana, et al.
Journal of Cutaneous Medicine and Surgery
|
October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults
Charles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
Jensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
BMC Rheumatology
|
December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
Christopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Frontiers in Medicine
|
August 27, 2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
Feras M Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Journal of Cutaneous Medicine and Surgery
|
April 25, 2006
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches
Richard G Langley, Vincent Ho, Charles Lynde, et al.
Journal of Drugs in Dermatology : JDD
|
October 11, 2022
Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis
Charles Lynde, Yves Poulin, Jerry Tan, et al.
Dermatology and Therapy
|
December 9, 2017
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
David Pariser, Ellen Frankel, Joel Schlessinger, et al.
Journal of Cutaneous Medicine and Surgery
|
February 23, 2018
OBSERVE-5: Comparison of Etanercept-Treated Psoriasis Patients From Canada and the United States
Kim A Papp, Marc Bourcier, Yves Poulin, et al.
Journal of the American Academy of Dermatology
|
September 21, 2010
Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population
Kim A Papp, Yves Poulin, Robert Bissonnette, et al.
Cutis
|
September 15, 2009
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne
Linda Stein Gold, Jerry Tan, Alma Cruz-Santana, et al.
Journal of Cutaneous Medicine and Surgery
|
October 31, 2017
A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults
Charles W Lynde, Marc Bourcier, Melinda Gooderham, et al.
Journal of Cutaneous Medicine and Surgery
|
June 6, 2020
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
Jensen Yeung, Melinda J Gooderham, Parbeer Grewal, et al.
BMC Rheumatology
|
December 5, 2019
Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
Christopher T Ritchlin, Mona Stahle, Yves Poulin, et al.
Frontiers in Medicine
|
August 27, 2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
Feras M Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Page
of 11